GeneLink Settles
Abby Olena | Jan 14, 2014
Another personal genomics company faces government pressure—this time from the Federal Trade Commission.
Federal Trade Commission Takes Action Against Stem Cell Clinics
Federal Trade Commission Takes Action Against Stem Cell Clinics
The FTC, in its first crack down on the industry, gets two California companies selling unproven treatments to stop their false advertising and pay a fine.
The FTC, in its first crack down on the industry, gets two California companies selling unproven treatments to stop their false advertising and pay a fine.
